Pulmonary artery pressure may be estimated non-invasively in the premature newborn infant because of its negative correlation with the time to peak velocity:right ventricular ejection time (TPV:RVET) ratio calculated from the pulmonary artery Doppler waveform. We studied 54 very low birthweight infants on days 1, 2, 3, 7, 14, 21, and 28 after birth. Thirty four infants developed chronic lung disease (CLD). Twenty did not and acted as controls. After correcting the TPV:RVET ratio for heart rate (TPV:RVET(c)), during the first 14 days the TPV:RVET(c) ratio rose progressively in both groups suggesting a fall in pulmonary artery pressure. This occurred at a significantly slower rate in the CLD group. From days 14 to 28 there was a significant fall in the ratio in the CLD group only, suggesting an increase in pulmonary artery pressure. Using CLD as the end point, a TPV:RVET(c) ratio <054 on day 7 had a predictive value of 78% (sensitivity 73%, specificity 65%). This rose to a predictive value of 97% (sensitivity 88%, specificity 95%) on day 28.
ported by postmortem studies on infants dying before 28 days of age. These have shown that the pulmonary vasculature has undergone changes consistent with an increase in pulmonary artery pressure. [10] [11] [12] By using Doppler echocardiography it is possible to assess non-invasively pulmonary artery pressure. There are two principle methods available. The first is triscupid regurgitation and ductal velocity patterns.13 14 The advantage of tricuspid regurgitation and ductal velocity is that it is possible to obtain a quantitative estimate of pulmonary artery pressure. However, these measurements are technically quite difficult and are not possible in all ventilated preterm infants. The disappearance of tricuspid regurgitation and closure of the ductus arteriosus in the majority of infants by 10 days precludes these methods from use in more prolonged studies. By contrast, the second method, measurement of the time to peak velocity:right ventricular ejection time (TPV:RVET) ratio,15-18 is possible in all infants and is relatively straightforward to measure using a standard ultrasound machine and it allows an assessment of the changes in pulmonary artery pressure. Both methods have shown good correlation with invasive measurements of pulmonary artery pressures in older infants and children. '9-22 Researchers using both methods showed that pulmonary artery pressure fell during the acute and early recovery phase of hyaline membrane disease. We are, however, unaware of any study that has been confined to the very low birthweight infant or where results have been correlated with the development of CLD.
The aims of this longitudinal study were twofold. Firstly, to study pulmonary artery pressure changes using the TPV:RVET ratio in very low birthweight infants with and without CLD. Secondly, to study the operating characteristics of this ratio as a means of identifying infants with CLD early in their postnatal course, potentially presenting a window of opportunity for therapeutic intervention.
Patients and methods All infants were studied using an ATL Ultramark 4 Using the Doppler measurement system incorporated into the machine, the following time intervals were measured. TPV was measured from the onset of ejection to peak velocity; RVET was measured from the onset to the cessation of ejection15 (fig 1) . The TPV:RVET ratio was corrected for heart rate by dividing by the square root of the R-R interval (TPV:RVET(c)). 22 (with Yates's correction) was used for analysis of numbers receiving positive pressure ventilation, ductal patency, and direction of ductal flow. The significance level was taken at 5%.
A peak pulmonary artery pressure of <30 mm Hg is considered to represent the upper limit of normal pulmonary artery pressure. [19] [20] [21] Previous studies have shown that the lower limit for the TPV:RVET in preterm infants is 0.34. [15] [16] The average heart rate of preterm infants less than 1501 g is 155 (R-R interval=0-390). 17 Therefore a TPV:RVET(c) of 0'54 probably represents the lower limit of pulmonary artery pressure in the preterm infant. Using CLD as the end point, we calculated the operating characteristics of a TPV:RVET(c) ratio <054 on each of the days of study.
The study was approved by the Liverpool Area Health Authority ethics committee and informed consent was obtained from the parents of each infant studied.
Results
There were 34 infants in the CLD group and 20 in the control group. Table 1 shows the demographic and clinical data for the two groups. Infants with CLD were of significantly lower birth weight and gestation when compared with the control group, p<0Q0001. The number of infants receiving positive pressure ventilation on each day of the study fell in both groups but there were significantly fewer ventilated infants in the control group from day 2 onwards. Table 2 shows the a-A ratio and the FiO2 on the day of study. The a-A ratio was significantly lower in the CLD group over the first three days. It was not possible to calculate the a-A ratio after this time as many infants did not have regular arterial oxygen tension measurements by means of an indwelling arterial catheter. The FiO2 from day 1 was Days after birth Figure 2 The TPV.RVET(c) ratio in CLD and control group by day of study.
X represents medians and closed bars interquartile range. Broken line represents lower limit ofpulmonary artery pressure, TPV:RVET(c)=0-54 (correctedfor heart rate). Figure 2 shows the change in the TPV:RVET(c) ratio on days 1, 2, 3, 7, 14, 21, and 28. Both groups of infants showed a rise in the TPV:RVET(c) ratio over the first 14 days after birth. However the CLD group had a significantly lower ratio from day 2 onwards when compared with the control group, p=0002. The difference in the ratio was due to a shorter TPV from day 3 onwards, p=0O0009 (table 3) , rather than due to differences in RVET or heart rate. The CLD group had a significant fall in the TPV:RVET(c) ratio from days 14 to 28, p=00007, whereas the ratio remained relatively constant in the control group, p=046. There was no correlation between the TPV:RVET(c) ratio on day 1 and birth weight or gestation. Right ventricular function was considered to be normal in all infants throughout the study. Table 4 shows the ductal patency and direction of ductal flow in both groups by day of study. Ductal patency fell from 100% on day 1 to 6% on day 28. In both groups of infants bidirectional flow occurred in the majority on day 1 becoming mainly left-right flow by day 3. There were no significant differences in the duration of ductal patency or direction of ductal flow in the two groups by day of study. Of the three infants in the CLD group with patent ducts on day 28, two underwent surgical ligation of the ductus arteriosus. Table 5 shows the operating characteristics of a TPV:RVET(c) ratio <0 54 in predicting CLD on the days of study. There was a progressive rise in the predictive value from 65% on day 1 to 97% on day 28. Other ratios (0A49-0-56) were considered in a similar way, but the optimal operating characteristics were obtained from a ratio of <0 54.
Discussion
Advances in neonatal intensive care have improved the survival of the very low birthweight infant but there has been an associated increase in the incidence of CLD.24
Pulmonary hypertension is invariably present in infants discharged home on supplemental oxygen5-9 but until now the changes in pulmonary pressure have not been studied longitudinally in the very low birthweight infant during the first 28 days. From the limited data available it appears that pulmonary hypertension plays an important part in the pathophysiology of this condition6 [10] [11] and has been linked to the increased incidence of cot death in infants with CLD.4
The TPV:RVET ratio is influenced by pulmonary artery pressure, myocardial contractility, and heart rate.25 Our subjective assessment was that all infants had normal right ventricular function. -The TPV, RVET and TPV:RVET are shortened as heart rate increases and therefore we corrected for this by dividing the ratio by the square root of the R-R interval.22 23 Kitabatake et al20 and Akibe et al22 showed a close negative correlation between this ratio and directly measured pulmonary artery pressure in older infants and children. For the purposes of our study we considered that a peak pulmonary pressure of 30 mm Hg represented the upper limit of normal pulmonary artery pressure.21 Using the regression equation quoted by Akibe et al this corresponds to a TPV:RVET(c) of 0 53. The infants studied by Evans and Archer'5-17 probably resemble our study population more closely, and from their results a TPV:RVET(c) of 0 54 being the lower limit of normal in the preterm infant. This figure was therefore chosen as the lower limit of normal pulmonary artery pressure. In fact, the operating characteristics were not significantly altered by using a figure of 053.
We found that there was a progressive fall in pulmonary artery pressure in both groups of infants over the first 14 days. However the rate of decrease was slower in the CLD group. This is probably explained by the fact that they had more severe hyaline membrane disease than the control group as reflected by the significantly lower a-A ratio and higher FiO2 during the first three days. The median TPV:RVET(c) in the CLD group never reached the same level as the control group but, more importantly, significantly fell from days 14 to 28 suggesting a progressive rise in pulmonary artery pressure. The change in the direction of ductal flow over the first seven days probably occurred as a result of the fall in pulmonary artery pressure as evidenced by the rise in the TPV:RVET(c) over the same period. It appeared to have no bearing on the changes in the TPV:RVET(c) ratio from day 14 to day 28.
The reason for the rise in pulmonary artery pressure is unclear but may be explained by the following pathological studies.
Tomashefski et al I I found that in those infants with hyaline membrane disease who died during the first two weeks after birth, the pulmonary vascular tree showed changes consistent with adaptation to extrauterine life by thinning of the smooth muscle lining the pulmonary arterioles and remodelling of the pulmonary vasculature, but the changes were at a slower rate than in the term infant. short term effects of intravenous nifedipine on a small group of infants who had invasive measurements of pulmonary artery pressure. There was a significant short lived fall in pulmonary artery pressure and pulmonary vascular resistance and the pharmacology suggested first order kinetics. In addition to present therapeutic manoeuvres, we speculate that in order to influence CLD severity, treatment could be aimed at trying to prevent the rise in pulmonary artery pressure early in the postnatal course. This could be done either indirectly by attempting to minimise the parenchymal lung damage or directly by using Crtf, Weindling group.bmj.com on July 7, 2017 -Published by http://adc.bmj.com/ Downloaded from pulmonary vasodilators. This might improve pulmonary perfusion, improve oxygenation, and break the cycle where hypoxia leads to further increases in vascular resistance.
Further studies are required to determine the extent to which this non-invasive assessment of pulmonary artery pressure can be used in the clinical management of the very low birthweight infant with CLD. 
